Search
Font size
- 1 2 3 + Font size

click to adjust

Page tools
Grants for Targets
Clinical Trials

Innovations for better health

Our research focuses mainly on therapeutic areas with significant unmet medical need. Every year, we invest between 15 and 17 percent of our total net sales in research and development.

In drug discovery we concentrate on new treatments in the fields of cancer, cardiovascular diseases and gynecological therapies, as well as new approaches to molecular imaging. To develop new drug candidates, we focus on identifying and optimizing small molecules and developing new biologics. more

http://www.bayerscheringpharma.de/scripts/pages/en/research_and_development/index.php

Copyright © Bayer Schering Pharma AG